Key Insights

Highlights

Success Rate

82% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

11.1%

3 terminated out of 27 trials

Success Rate

82.4%

-4.2% vs benchmark

Late-Stage Pipeline

15%

4 trials in Phase 3/4

Results Transparency

14%

2 of 14 completed with results

Key Signals

2 with results82% success

Data Visualizations

Phase Distribution

20Total
Not Applicable (7)
Early P 1 (1)
P 1 (3)
P 2 (5)
P 3 (3)
P 4 (1)

Trial Status

Completed14
Withdrawn6
Terminated3
Active Not Recruiting1
Unknown1
Not Yet Recruiting1

Trial Success Rate

82.4%

Benchmark: 86.5%

Based on 14 completed trials

Clinical Trials (27)

Showing 20 of 20 trials
NCT07535502Not ApplicableNot Yet RecruitingPrimary

Food is Medicine in Pediatric Patients With Diabetes

NCT06739811Not ApplicableRecruitingPrimary

Clinical Evaluation of the Medtronic Implantable Insulin Pump System (MIIPS 2020) in Adult Subjects With Type 1 Diabetes (CIP347)

NCT06964087Phase 2Active Not RecruitingPrimary

Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus

NCT04279613Phase 1CompletedPrimary

A Multiple Ascending Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0361-0041

NCT06674135Phase 4CompletedPrimary

Evaluating the Impact of Introducing Basaglar, a Long-acting Analog Insulin, on Clinical and Quality of Life Outcomes in Youth with Diabetes in Bangladesh

NCT06242548Not ApplicableCompleted

How Type I Diabetes Responds to Different Diets (Normoglucidic or Ketogenic) During Physical Activity at Altitude

NCT05035368Phase 2WithdrawnPrimary

Ladarixin as Adjunctive Therapy to Improve Insulin Sensitivity and Glucometabolic Outcomes in Type 1 Diabetes

NCT01308437Phase 3TerminatedPrimary

Immunosafety Study of Recombinant Human Insulins in Type 1 Diabetics

NCT05151770CompletedPrimary

Type 1 Diabetic Post Prandial Glycemia Evaluation Using an Algorithm

NCT01652911Phase 1TerminatedPrimary

A Phase I/II Study of the Safety and Efficacy of Sernova's Cell PouchTM for Therapeutic Islet Transplantation

NCT02002130Phase 1CompletedPrimary

The Use of Glutamic Acid Decarboxylase (GAD) and Gamma-Amino Butyric Acid (GABA) in the Treatment of Type I Diabetes

NCT05160142Early Phase 1CompletedPrimary

Diabetes Inspired Culinary Education

NCT03653533Not ApplicableTerminatedPrimary

Evaluation of the Function "Stop Before Hypoglycemia" on External Insulin Pump

NCT01928329Phase 2CompletedPrimary

A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes

NCT00999375Phase 2CompletedPrimary

Cultivating Healthy Environments in Families With Type 1 Diabetes (CHEF)

NCT02634216Not ApplicableCompletedPrimary

Effects of Capros in Patients With Type-1 Diabetes

NCT01352663Phase 3WithdrawnPrimary

Immunogenicity Safety Study of Wockhardt's Recombinant Insulin Analogue in Type 1 Diabetic Patients

NCT01477476Phase 2WithdrawnPrimary

Anti-IL-1 Treatment in Children Diabetic Keto-Acidosis (DKA) at Diagnosis of Type 1 Diabetes

NCT02127762Not ApplicableCompleted

The Effect of Mindfulness Based Stress Reduction in Patients With Painful Diabetic Peripheral Neuropathy

NCT00340639CompletedPrimary

Management of Type 1 Diabetes Among Adolescents

Scroll to load more

Research Network

Activity Timeline